| 摘要 |
The present invention provides methods for identifying mutations in human chromosome 1p using an insulin/relaxin family member, designated zins3. The invention also provides methods for determining mutations in the zins3 gene are linked to defects in glucose metabolism, such as diabetes. The present invention also provides methods for identifying polymorphisms that result from mutations in the zins3 gene on chromosome 1p, a loci linked with a heritable form of NIDDM. |
